MHC class II-mediated apoptosis by a nonpolymorphic MHC class II peptide proceeds by activation of protein kinase C

Journal of the American Society of Nephrology

Volumn 16, Issue 12, 2005, Pages 3661-3668

  Zang, Weiping ^a   Kalache, Safa ^a   Lin, Marvin ^a   Schroppel, Bernd ^a   Murphy, Barbara ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HLA DQA1 ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; PROTEIN KINASE C; HLA DQ ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN BINDING; ANTIGEN PRESENTING CELL; APOPTOSIS; ARTICLE; B LYMPHOCYTE; BINDING SITE; CELL DEATH; CONTROLLED STUDY; ENZYME ACTIVATION; MALE; MEMBRANE DEPOLARIZATION; MITOCHONDRIAL MEMBRANE; MOUSE; NONHUMAN; PRIORITY JOURNAL; ANIMAL; BAGG ALBINO MOUSE; C57BL MOUSE; CELL CULTURE; COMPARATIVE STUDY; DISEASE MODEL; DRUG EFFECT; GENE; METABOLISM; MOUSE MUTANT; PHYSIOLOGY; SENSITIVITY AND SPECIFICITY; SIGNAL TRANSDUCTION;

ANIMALS; APOPTOSIS; BINDING SITES; CELLS, CULTURED; DISEASE MODELS, ANIMAL; ENZYME ACTIVATION; GENES, MHC CLASS II; HLA-DQ ANTIGENS; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; MITOCHONDRIAL MEMBRANES; PROTEIN KINASE C; SENSITIVITY AND SPECIFICITY; SIGNAL TRANSDUCTION;

EID: 33645927666     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1681/ASN.2005050523     Document Type: Article

References (46)

1. Reinherz EL, Tan K, Tang L, Kern P, Liu J, Xiong Y, Hussey RE, Smolyar A, Hare B, Zhang R, Joachimiak A, Chang HC, Wagner G, Wang J: The crystal structure of a T cell receptor in complex with peptide and MHC class II. Science 286: 1913-1921, 1999
2. Waaga AM, Murphy B, Sayegh MH: MHC derived peptides: A novel form of immunosuppression. Curr Opin Trans 4: 211-218, 1999
3. Murphy B, Sayegh MH: Immunomodulatory function of MHC-derived peptides. Curr Opin Nephrol Hypertens 5: 262-268, 1996
4. Sloan-Lancaster J, Shaw AS, Rothbard JB, Allen PM: Partial T cell signaling: Altered phospho-zeta and lack of zap70 recruitment in APL-induced T cell anergy. Cell 79: 913-922, 1994
5. Verhoef A, Lamb JR: Threshold signaling of human Th0 cells in activation and anergy: Modulation of effector function by altered TCR ligand. J Immunol 164: 6034-6040, 2000
6. Nicholson LB, Murtaza A, Hafler BP, Sette A, Kuchroo VK: A T cell receptor antagonist peptide induces T cells that mediate bystander suppression and prevent autoimmune encephalomyelitis induced with multiple myelin antigens. Proc Natl Acad Sci U S A 94: 9279-9284, 1997
7. Young DA, Lowe LD, Booth SS, Whitters MJ, Nicholson L, Kuchroo VK, Collins M: IL-4, IL-10, IL-13, and TGF-beta from an altered peptide ligand-specific Th2 cell clone down-regulate adoptive transfer of experimental autoimmune encephalomyelitis. J Immunol 164: 3563-3572, 2000
8. Sayegh MH, Khoury SK, Hancock WW, Weiner HL, Carpenter CB: Induction of immunity and oral tolerance with polymorphic class II MHC allopeptides in the rat. Proc Natl Acad Sci U S A 89: 7762-7766, 1992
9. Sayegh MH, Perico N, Gallon L, Imberti O, Hancock WW, Remuzzi G, Carpenter CB: Mechanisms of acquired thymic unresponsiveness to renal allografts: Thymic recognition of immunodominant allo-MHC peptides induces peripheral T cell anergy. Transplantation 58: 125-130, 1994
10. Chai JG, James E, Dewchand H, Simpson E, Scott D: Transplantation tolerance induced by intranasal administration of HY peptides. Blood 103: 3951-3959, 2004
11. Murphy B, Krensky AM: HLA-derived peptides as novel immunomodulatory therapeutics. J Am Soc Nephrol 10: 1346-1355, 1999
12. Iyer S, Kontoyiannis D, Chevrier D, Woo J, Mori N, Cornejo M, Kollias G, Buelow R: Inhibition of tumor necrosis factor mRNA translation by a rationally designed immunomodulatory peptide. J Biol Chem 275: 17051-17057, 2000
13. Buelow R, Veyron P, Clayberger C, Pouletty P, Touraine J-L: Prolongation of skin allograft survival in mice following administration of allotrap. Transplantation 59: 455-460, 1995
14. Nisco S, Vriens P, Hoyt G, Lyu SC, Farfan F, Pouletty P, Krensky AM, Clayberger C: Induction of allograft tolerance in rats by an HLA-class I derived peptide and cyclosporine A. J Immunol 152: 3786-3792, 1994
15. Murphy B, Kim KS, Buelow R, Sayegh MH, Hancock WW: Synthetic MHC class I peptide prolongs cardiac survival and attenuates transplant arteriosclerosis in the Lewis→ Fischer 344 model of chronic rejection. Transplantation 64: 14-19, 1997
16. Bourreille A, Doubremelle M, de la Bletiere DR, Segain JP, Toquet C, Buelow R, Galmiche JP: RDP58, a novel immunomodulatory peptide with anti-inflammatory effects. A pharmacological study in trinitrobenzene sulphonic acid colitis and Crohn disease. Scand J Gastroenterol 38: 526-532, 2003
17. Boytim ML, Lyu SC, Jung R, Krensky AM, Clayberger C: Inhibition of cell cycle progression by a synthetic peptide corresponding to residues 65-79 of an HLA class II sequence: Functional similarities but mechanistic differences with the immunosuppressive drug rapamycin. J Immunol 160: 2215-2222, 1998
18. Dong C, Lyu SC, Krensky AM, Clayberger C: DQ 65-79, a peptide derived from HLA class II, mimics p21 to block T cell proliferation. J Immunol 171: 5064-5070, 2003
19. Murphy B, Magee CC, Alexander SI, Waaga AM, Snoeck HW, Vella JP, Carpenter CB, Sayegh MH: Inhibition of allorecognition by a human class II MHC-derived peptide through the induction of apoptosis. J Clin Invest 103: 859-867, 1999
20. Murphy B, Yu J, Jiao Q, Lin M, Chitnis T, Sayegh MH: A novel mechanism for the immunomodulatory functions of class II MHC-derived peptides. J Am Soc Nephrol 14: 1053-1065, 2003
21. Murphy B, Auchincloss H Jr, Carpenter CB, Sayegh MH: T cell recognition of xeno-MHC peptides during concordant xenograft rejection. Transplantation 61: 1133-1137, 1996
22. Pathak SS, Blum JS: Endocytic recycling is required for the presentation of an exogenous peptide via MHC class II molecules. Traffic 1: 561-569, 2000
23. Rodal SK, Skretting G, Garred O, Vilhardt F, van Deurs B, Sandvig K: Extraction of cholesterol with methyl-beta-cyclodextrin perturbs formation of clathrin-coated endocytic vesicles. Mol Biol Cell 10: 961-974, 1999
24. Guo W, Castaigne JG, Mooney N, Charron D, Al-Daccak R: Signaling through HLA-DR induces PKC beta-dependent B cell death outside rafts. Eur J Immunol 33: 928-938, 2003
25. Leverkus M, McLellan AD, Heldmann M, Eggert AO, Brocker EB, Koch N, Kampgen E: MHC class II-mediated apoptosis in dendritic cells: A role for membrane-associated and mitochondrial signaling pathways. Int Immunol 15: 993-1006, 2003
26. Tabata H, Matsuoka T, Endo F, Nishimura Y, Matsushita S: Ligation of HLA-DR molecules on B cells induces enhanced expression of IgM heavy chain genes in association with Syk activation. J Biol Chem 275: 34998-35005, 2000
27. al-Daccak R, Damaj B, Naccache PH, Mourad W: Superantigens initiate cognate CD4+ T cell/B cell interactions leading to early activation and proliferation of B cells. Eur J Immunol 25: 2539-2543, 1995
28. Drenou B, Blancheteau V, Burgess DH, Fauchet R, Charron DJ, Mooney NA: A caspase-independent pathway of MHC class II antigen-mediated apoptosis of human B lymphocytes. J Immunol 163: 4115-4124, 1999
29. Nagy ZA, Hubner B, Lohning C, Rauchenberger R, Reiffert S, Thomassen-Wolf E, Zahn S, Leyer S, Schier EM, Zahradnik A, Brunner C, Lobenwein K, Rattel B, Stanglmaier M, Hallek M, Wing M, Anderson S, Dunn M, Kretzschmar T, Tesar M: Fully human, HLA-DR-specific monoclonal antibodies efficiently induce programmed death of malignant lymphoid cells. Nat Med 8: 801-807, 2002
30. Wall KA, Lorber MI, Loken MR, McClatchey S, Fitch FW: Inhibition of proliferation of Mis- and Ia-reactive cloned T cells by a monoclonal antibody against a determinant shared by I-A and I-E. J Immunol 131: 1056-1064, 1983
31. Tompkins SM, Moore JC, Jensen PE: An insulin peptide that binds an alternative site in class II major histocompatibility complex. J Exp Med 183: 857-866, 1996
32. Truman JP, Choqueux C, Charron D, Mooney N: HLA class II molecule signal transduction leads to either apoptosis or activation via two different pathways. Cell Immunol 172: 149-157, 1996
33. Al-Daccak R, Mooney N, Charron D: MHC class II signaling in antigen-presenting cells. Curr Opin Immunol 16:108-113, 2004
34. Bertho N, Drenou B, Laupeze B, Berre CL, Amiot L, Grosset JM, Fardel O, Charron D, Mooney N, Fauchet R: HLA-DR-mediated apoptosis susceptibility discriminates differentiation stages of dendritic/monocytic APC. J Immunol 164: 2379-2385, 2000
35. Truman JP, Garban F, Choqueux C, Charron D, Mooney N: HLA class II signaling mediates cellular activation and programmed cell death. Exp Hematol 24: 1409-1415, 1996
36. Lokshin AE, Kalinski P, Sassi RR, Mailliard RB, Muller-Berghaus J, Storkus WJ, Peng X, Marrangoni AM, Edwards RP, Gorelik E: Differential regulation of maturation and apoptosis of human monocyte-derived dendritic cells mediated by MHC class II. Int Immunol 14: 1027-1037, 2002
37. Gambier JC, Newell MK, Justement LB, McGuire JC, Leach KL, Chen ZZ: Ia binding ligands and cAMP stimulate nuclear translocation of PKC in B lymphocytes. Nature 327: 629-632, 1987
38. Bertho N, Blancheteau VM, Setterblad N, Laupeze B, Lord JM, Drenou B, Amiot L, Charron DJ, Fauchet R, Mooney N: MHC class II-mediated apoptosis of mature dendritic cells proceeds by activation of the protein kinase C-delta isoenzyme. Int Immunol 14: 935-942, 2002
39. Harton JA, Van Hagen AE, Bishop GA: The cytoplasmic and transmembrane domains of MHC class II beta chains deliver distinct signals required for MHC class II-mediated B cell activation. Immunity 3: 349-358, 1995
40. Rich T, Lawler SE, Lord JM, Blancheteau VM, Charron DJ, Mooney NA: HLA class II-induced translocation of PKC alpha and PKC beta II isoforms is abrogated following truncation of DR beta cytoplasmic domains. J Immunol 159: 3792-3798, 1997
41. Setterblad N, Becart S, Charron D, Mooney N: Signalling via MHC class II molecules modifies the composition of GEMs in APC. Scand J Immunol 54: 87-92, 2001
42. Leist M, Jaattela M: Four deaths and a funeral: From caspases to alternative mechanisms. Nat Rev Mol Cell Biol 2: 589-598, 2001
43. Barrett CM, Lewis FL, Roaten JB, Sweatman TW, Israel M, Cleveland JL, Lothstein L: Novel extranuclear-targeted anthracyclines override the antiapoptotic functions of Bcl-2 and target protein kinase C pathways to induce apoptosis. Mol Cancer Ther 1: 469-481, 2002
44. Nowak G: Protein kinase C-alpha and ERK1/2 mediate mitochondrial dysfunction, decreases in active Na+ transport, and cisplatin-induced apoptosis in renal cells. J Biol Chem 277: 43377-43388, 2002
45. Majumder PK, Pandey P, Sun X, Cheng K, Datta R, Saxena S, Kharbanda S, Kufe D: Mitochondrial translocation of protein kinase C delta in phorbol ester-induced cytochrome c release and apoptosis. J Biol Chem 275: 21793-21796, 2000
46. Sun XM, MacFarlane M, Zhuang J, Wolf BB, Green DR, Cohen GM: Distinct caspase cascades are initiated in receptor-mediated and chemical-induced apoptosis. J Biol Chem 274: 5053-5060, 1999